EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer-Reference-Cited by-同舟云学术

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer

Published:2013-12-30 Issue:5 Volume:35 Page:1100-1109
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Bradley Amber,Zheng Hui,Ziebarth Angela,Sakati Wayne,Branham-O’Connor Melissa,Blumer Joe B.,Liu Yuying,Kistner-Griffin Emily,Rodriguez-Aguayo Cristian,Lopez-Berestein Gabriel,Sood Anil K.,Landen Charles N.,Eblen Scott T.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/35/5/1100/14132924/bgt489.pdf

Reference47 articles.

1. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro;O’Brien;Br. J. Cancer,(2008)

2. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response;Henderson;J. Biol. Chem.,(2002)

3. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD;Bethard;J. Proteomics,(2011)

4. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs;Eblen;J. Biol. Chem.,(2003)

5. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors;Rechsteiner;Trends Cell Biol.,(2005)

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling;Redox Biology;2024-10

2. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?;International Journal of Surgery;2024-05-03

3. The role of UBR5 in tumor proliferation and oncotherapy;Gene;2024-05

4. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28

5. Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals;Saudi Pharmaceutical Journal;2023-06